Tag: Hetero

Zim among top priority lenacapavir recipients as Gilead licenses Hetero

Kuda Pembere

By Kuda Pembere With Zimbabwe being among the 18 top-priority recipients of lenacapavir an HIV preventive drug pending local medicines regulatory approvals, Gilead Sciences, the principal maker has granted a non-exclusive license to leading India headquartered pharmaceutical manufacturer Hetero Group of Companies to manufacture and supply the drug. Gilead’s decision comes following much advocacy by AVAC to give non-exclusive licenses for the manufacturing of lenapavir. The partnership will broaden access to this novel HIV treatment usable in combination with other antiretrovirals while supporting efforts to prevent HIV through pre-exposure prophylaxis…

Read More

Hetero bags first world WHO prequalification of medicines programme generic version of Pfizer’s Covid-19 oral drug

Kuda Pembere

A leading global pharmaceutical manufacturer Hetero Group emerged the first company in the world to be accorded the World Health Organisation’s (WHO) prequalification of medicines programme (WHO-PQ) for its generic version of Covid-19 oral antiviral treatment candidate Nirmatrelvir. This antiviral with Ritonavir is used as part of Pfizer’s Paxlovid. The company said it, “will be rolling out its generic combi-pack under the NIRMACOM brand that will contain 150mg tablets of Nirmatrelvir and 100mg tablets of Ritonavir.” The WHO deemed the drug, Nirmatrelvir, the best option for high risk patients. “This…

Read More